Heritage Cannabis Holdings Subsidiary CannaCure Receives Sales License from Health Canada

TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), is pleased to announce that its subsidiary CannaCure Corp. (“CannaCure”) has been granted a cannabis oil sales license by Health Canada, effective October 9, 2020. This sales license will allow CannaCure to begin selling cannabis products, including oil derivatives, directly to the provincial cannabis boards.Continue reading “Heritage Cannabis Holdings Subsidiary CannaCure Receives Sales License from Health Canada”

Heritage Cannabis Teams with Patient Choice to Offer Medical Cannabis to Patients Across Canada

Purefarma and Pura Vida now available through new Health Canada licensed platform TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage”or the “Company”), today announced that its products, including the Purefarma and Pura Vida brands, are available for purchase on the Patient Choice online platform. Patient Choice is a Health Canada licensed virtual portal that gives medical cannabisContinue reading “Heritage Cannabis Teams with Patient Choice to Offer Medical Cannabis to Patients Across Canada”

Heritage Cannabis Announces Launch of Purefarma Hemplixers and Pura Vida CBD Tincture and 4:1 CBD Vape Cartridge.

– Heritage Cannabis Holdings Corp. (CSE:CANN) (CNSX:CANN.CN) (OTC:HERTF) (“Heritage” or the “Company“), today announced that it will launch the popular Purefarma Hemplixer full spectrum CBD tinctures in British Columbia, Alberta, and Manitoba this summer. Hemplixer will be available in two concentrations: HLX15 and HLX30, with retail prices in the mid $30s and mid $50s respectively for 30 ml bottles. A long-established and much anticipatedContinue reading “Heritage Cannabis Announces Launch of Purefarma Hemplixers and Pura Vida CBD Tincture and 4:1 CBD Vape Cartridge.”